Since the role of CRIP1 in osteosarcomas has not been studied so far, we investigated a set of 223 pretherapeutic tumor samples immunohistochemically and correlated our findings with clinico-pathological parameters to also identify potential prognostic implications of CRIP1 in these aggressive tumors of bone. Here, CRIP1 is linked to neoplasm.